IRES-based RNAs encoding 4-1BB, OX40L, and ICOSL enhanced T cell immunity and suppressed tumor progression by promoting immune infiltration and attenuating T cell exhaustion and regulatory T cell expansion in lymphoid organs, supporting their potential as RNA-based platforms for rationally designed cancer immunotherapy. The gene discussed is TNFSF4; the disease is neoplasm.